Profound Medical Corporation (PROF) Q1 2025 Earnings Conference Call Transcript

Group 1 - Profound Medical Corporation held its Q1 2025 earnings conference call on May 8, 2025, at 4:30 PM ET [1] - The call featured key company participants including the Head of Investor Relations, CFO, COO, Chief Commercial Officer, and CEO [1] - The conference call was recorded and included a question and answer session following the presentations [1] Group 2 - The Head of Investor Relations, Stephen Kilmer, initiated the call and mentioned that it would include forward-looking statements as per applicable securities laws in the US and Canada [2][3] - Forward-looking statements are based on the company's current beliefs and expectations regarding future financial performance and the efficacy of its technologies in treating various medical conditions [3] - The company cautioned listeners about the inherent risks and uncertainties associated with forward-looking statements, emphasizing that actual results may differ materially from those implied [3]